Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Knight Cancer Institute Study of Histology-Agnostic Immunotherapy With Focus on Timing: - Knight SHIFT - A Prospective, Multi-Histology Pragmatic Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07405086
Title field or adapter rule
{'original_value': 'Knight Cancer Institute Study of Histology-Agnostic Immunotherapy With Focus on Timing: - Knight SHIFT - A Prospective, Multi-Histology Pragmatic Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:36.748726+00:00
Published At
2026-10-13T00:00:00+00:00
Record Updated At
2026-10-13
Source Retrieved At
2026-10-31T22:19:02.163121+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Biliary Tract Carcinoma", "Advanced Head and Neck Squamous Cell Carcinoma", "Advanced Hepatocellular Carcinoma", "Advanced Lung Non-Small Cell Carcinoma", "Advanced Malignant Solid Neoplasm", "Advanced Melanoma", "Advanced Renal Cell Carcinoma", "Metastatic Biliary Tract Carcinoma", "Metastatic Head and Neck Squamous Cell Carcinoma", "Metastatic Hepatocellular Carcinoma", "Metastatic Lung Non-Small Cell Carcinoma", "Metastatic Malignant Solid Neoplasm", "Metastatic Melanoma", "Metastatic Renal Cell Carcinoma", "Recurrent Head and Neck Squamous Cell Carcinoma", "Stage III Hepatocellular Carcinoma AJCC v8", "Stage III Lung Cancer AJCC v8", "Stage III Renal Cell Cancer AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-13", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07405086"
protocolSection.identificationModule.officialTitle
"Knight Cancer Institute Study of Histology-Agnostic Immunotherapy With Focus on Timing: - Knight SHIFT - A Prospective, Multi-Histology Pragmatic Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Advanced Biliary Tract Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Advanced Melanoma (protocolSection.conditionsModule.conditions)
  • Advanced Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Biliary Tract Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Melanoma (protocolSection.conditionsModule.conditions)
  • Metastatic Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Renal Cell Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Renal Cell Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Treatment (AM cohort)', 'Treatment (PM cohort)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (AM cohort)', 'Treatment (PM cohort)'], 'description': 'Receive immune checkpoint inhibitor therapy', 'name': 'Immune Checkpoint Inhibitor', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Immune Checkpoint Inhibitor (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.